PJL Life Sciences ApS: Financial statements 2024
CVR: 42773883
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PJL Life Sciences ApS (CVR 42773883) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 94,573 and a net result of DKK 73,783 compared with DKK 35,022 the year before. That is an increase of 110.6% compared with the year before. Equity in the 2024 report amounted to DKK 213,094. The solvency ratio was 29.3%.
- Gross Profit
- DKK 94,573
- Profit/Loss
- DKK 73,783
- Equity
- DKK 213,094
- Total Assets
- DKK 727,048
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 95 t. | 74 t. | 213 t. | - |
| 2023 | - | 45 t. | 35 t. | 139 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PJL Life Sciences ApS has published its annual report for 2023. Gross profit came to DKK 44,900, and the net result was DKK 35,022.
About PJL Life Sciences ApS
PJL Life Sciences ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Philip Just Larsen. The company is owned by Philip Just Larsen. In 2025, the company reported a gross profit of DKK 61,012 and a net result of DKK 46,736 compared with DKK 73,783 the year before. Equity in the 2025 report amounted to DKK 259,830.